BE796279A - Procede de preparation de nouvelles 2,6-diamino-dihydropyridines - Google Patents

Procede de preparation de nouvelles 2,6-diamino-dihydropyridines

Info

Publication number
BE796279A
BE796279A BE128374A BE128374A BE796279A BE 796279 A BE796279 A BE 796279A BE 128374 A BE128374 A BE 128374A BE 128374 A BE128374 A BE 128374A BE 796279 A BE796279 A BE 796279A
Authority
BE
Belgium
Prior art keywords
dihydropyridines
diamino
preparing new
preparing
new
Prior art date
Application number
BE128374A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of BE796279A publication Critical patent/BE796279A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
BE128374A 1972-03-06 1973-03-05 Procede de preparation de nouvelles 2,6-diamino-dihydropyridines BE796279A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2210687A DE2210687C3 (de) 1972-03-06 1972-03-06 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
BE796279A true BE796279A (fr) 1973-09-05

Family

ID=5838037

Family Applications (1)

Application Number Title Priority Date Filing Date
BE128374A BE796279A (fr) 1972-03-06 1973-03-05 Procede de preparation de nouvelles 2,6-diamino-dihydropyridines

Country Status (24)

Country Link
JP (2) JPS5626659B2 (fr)
KR (1) KR780000119B1 (fr)
AT (3) AT327904B (fr)
BE (1) BE796279A (fr)
BG (2) BG20583A3 (fr)
CA (1) CA988524A (fr)
CH (2) CH577473A5 (fr)
CS (2) CS182781B2 (fr)
DD (1) DD106833A5 (fr)
DE (1) DE2210687C3 (fr)
DK (1) DK136061C (fr)
ES (1) ES412323A1 (fr)
FI (1) FI55996C (fr)
FR (1) FR2181789B1 (fr)
GB (1) GB1379005A (fr)
HU (1) HU167089B (fr)
IE (1) IE37370B1 (fr)
IL (1) IL41664A (fr)
LU (1) LU67147A1 (fr)
NL (1) NL7303137A (fr)
PL (2) PL92078B1 (fr)
RO (2) RO61192A (fr)
SE (1) SE384208B (fr)
ZA (1) ZA731501B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2210687C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2406198C2 (de) * 1974-02-09 1983-12-15 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von neuen 2-Amino-6-dialkylamino-dihydropyridinen
JPS5922593U (ja) * 1982-08-03 1984-02-10 日本マランツ株式会社 ヘツドホ−ン用ホ−ン部取付構造
JPS5922594U (ja) * 1982-08-03 1984-02-10 日本マランツ株式会社 耳栓型ヘツドホ−ン
JPS6282898A (ja) * 1985-10-08 1987-04-16 Matsushita Electric Ind Co Ltd ヘツドホン
JPS6293060U (fr) * 1985-11-28 1987-06-13

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2210687C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
US3855231A (en) * 1972-03-06 1974-12-17 Bayer Ag 2,6-diamino-1,4-dihydropyridine derivatives
DE2406198C2 (de) * 1974-02-09 1983-12-15 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von neuen 2-Amino-6-dialkylamino-dihydropyridinen

Also Published As

Publication number Publication date
BG22815A3 (fr) 1977-04-20
ATA925774A (de) 1975-05-15
DK136061B (da) 1977-08-08
ZA731501B (en) 1973-11-28
CH577473A5 (fr) 1976-07-15
AT324338B (de) 1975-08-25
IL41664A (en) 1976-01-30
DK136061C (da) 1978-01-02
AT327904B (de) 1976-02-25
IE37370L (en) 1973-09-06
CH580589A5 (fr) 1976-10-15
PL89256B1 (fr) 1976-11-30
FR2181789B1 (fr) 1976-12-03
DE2210687A1 (de) 1973-09-20
CS182792B2 (en) 1978-05-31
NL7303137A (fr) 1973-09-10
CA988524A (en) 1976-05-04
IL41664A0 (en) 1973-05-31
DE2210687B2 (de) 1980-09-04
PL92078B1 (fr) 1977-03-31
FI55996B (fi) 1979-07-31
IE37370B1 (en) 1977-07-06
KR780000119B1 (en) 1978-04-15
BG20583A3 (fr) 1975-12-05
RO61192A (fr) 1976-09-15
JPS5911584B2 (ja) 1984-03-16
DE2210687C3 (de) 1981-09-24
DD106833A5 (fr) 1974-07-05
GB1379005A (en) 1975-01-02
JPS48103579A (fr) 1973-12-25
ES412323A1 (es) 1976-01-01
FI55996C (fi) 1979-11-12
LU67147A1 (fr) 1973-05-22
CS182781B2 (en) 1978-05-31
RO63068A (fr) 1978-05-15
HU167089B (fr) 1975-08-28
JPS5626659B2 (fr) 1981-06-19
FR2181789A1 (fr) 1973-12-07
SE384208B (sv) 1976-04-26
JPS5699460A (en) 1981-08-10

Similar Documents

Publication Publication Date Title
BE768485A (fr) Procede de preparation d'aryloxy-1,1,2,2-tetrafluoro-ethanes
BE799033A (fr) Procede de preparation de solutions de polyurethane-urees,
CH552626A (fr) Procede de preparation d'ureido-cephalosporines heterocycliques.
BE799029A (fr) Procede de preparation de solutions de polyurethane-urees,
BE799532A (fr) Procede de preparation de thiocarbamylsulfenamides,
BE786840A (fr) Procede de preparation de 1,2,4-triazine -5-ones
BE804942A (fr) Procede de preparation de cyclohexane-diones (1,3)
BE808733A (fr) Procede de preparation de cyclohexane-diones-1,3
BE766264A (fr) Procede de preparation de 1,2-benzisothiazoline-3-ones
BE802638A (fr) Procede de preparation de dioxo-3,20 steroides
BE795020A (fr) Procede de preparation de nouvelles diazepines
BE797346A (fr) Procede de preparation de 1-hydroxy-2-pyridones
BE805635A (fr) Procede de preparation de thiazolsulfenamides
BE803773A (fr) Procede de preparation d'aminobenzenes
BE817226A (fr) Procede de preparation de la 4,5-diphenyloxazole-2-one.
BE804709A (fr) Procede de preparation du 1,4-diacetoxybutane
BE796279A (fr) Procede de preparation de nouvelles 2,6-diamino-dihydropyridines
BE804528A (fr) Procede de preparation de trans-chrysanthemates d'almyle
BE810087A (fr) Procede de preparation de triceto-2,4,5- imidazolidines
BE795782A (fr) Procede de preparation de la 2,4-dihydroxy-benzophenone
CH553785A (fr) Procede de preparation de nouvelles dibenzoazepines.
BE799198A (fr) Procede de preparation d'amindazetidinones,
BE803370A (fr) Procede de preparation d'amino-anthraquinones
BE807204A (fr) Procede de preparation de thiazolsulfenamides
BE804619A (fr) Procede de preparation d'halophenoxynitrobenzoates

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BAYER A.G.

Effective date: 19840305